ACCESSION: MSBNK-SMB_Measured-HSA015P0371002
RECORD_TITLE: Characterized; Octaethylene glycol; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'EL03_pos_3116': {'bp': 316231.0, 'sum': 730844.0}, 'EL24_pos_3028': {'bp': 251754.0, 'sum': 505652.0}, 'EL01_pos_3017': {'bp': 248515.0, 'sum': 487255.0}, 'EL06_pos_3011': {'bp': 203339.0, 'sum': 407568.0}, 'EL05_pos_3022': {'bp': 185349.0, 'sum': 393943.0}, 'EL08_pos_3014': {'bp': 172865.0, 'sum': 356489.0}, 'EL09_pos_3010': {'bp': 167077.0, 'sum': 333962.0}, 'EL04_pos_3016': {'bp': 162868.0, 'sum': 330903.0}, 'EL16_pos_3009': {'bp': 162234.0, 'sum': 337310.0}, 'EL17_pos_3005': {'bp': 156506.0, 'sum': 323951.0}, 'EL23_pos_3021': {'bp': 150881.0, 'sum': 309987.0}, 'EL02_pos_3035': {'bp': 145973.0, 'sum': 307104.0}, 'EL18_pos_3017': {'bp': 145356.0, 'sum': 285319.0}, 'EL11_pos_3015': {'bp': 139164.0, 'sum': 287087.0}, 'EL07_pos_3004': {'bp': 137693.0, 'sum': 280733.0}, 'EL10_pos_3015': {'bp': 133351.0, 'sum': 286682.0}, 'EL19_pos_3032': {'bp': 126263.0, 'sum': 264204.0}, 'EL20_pos_3005': {'bp': 124006.0, 'sum': 237305.0}, 'EL21_pos_3015': {'bp': 114687.0, 'sum': 240996.0}, 'EL13_pos_3016': {'bp': 112285.0, 'sum': 236939.0}, 'EL22_pos_3043': {'bp': 101601.0, 'sum': 209982.0}, 'EL14_pos_3029': {'bp': 92709.0, 'sum': 203164.0}, 'EL12_pos_3017': {'bp': 91661.0, 'sum': 199379.0}, 'EL15_pos_3021': {'bp': 82935.0, 'sum': 190693.0}}
COMMENT: RETENTION_TIME_STDEV 0.022
COMMENT: PRECURSOR_M/Z_RAW 371.227558
COMMENT: PRECURSOR_M/Z_STDEV 0.000142
COMMENT: PRECURSOR_IN_MS1 mz 371.227507; int 89.430; delta(ppm) 1.071382
COMMENT: PROPOSED_CHARGE_STATE +1; mz 372.231146; int 16.581; cor 0.860
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+NH4; mz 388.254118; int 107.064; cor 0.903
COMMENT: PROPOSED_ION_FORM M+H; M+Na; mz 393.209373; int 92.275; cor 0.941
COMMENT: PROPOSED_ION_FORM M+H; M+K; mz 409.183236; int 11.475; cor 0.785
COMMENT: PROPOSED_ION_FORM M+Na; M+2Na-H; mz 393.209373; int 92.275; cor 0.941
COMMENT: PROPOSED_ION_FORM M+K; M+2K-H; mz 409.183236; int 11.475; cor 0.785
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 3.695; C17H30N4O5; [M+H]+; delta(ppm) -3.695098
COMMENT: PROPOSED_MF SevenGoldenRules 0.084; C16H34O9; [M+H]+; delta(ppm) -0.083734
COMMENT: PROPOSED_MF SevenGoldenRules 3.247; C20H36O2P2; [M+H]+; delta(ppm) 3.246716
COMMENT: PROPOSED_MF SevenGoldenRules 2.986; C15H32N4O5; [M+Na]+; delta(ppm) 2.986461
COMMENT: PROPOSED_MF SevenGoldenRules 3.262; C22H37P; [M+K]+; delta(ppm) 3.262462
COMMENT: PROPOSED_MF MS-FINDER 3.586; C16H34O9; [M+H]+; delta(ppm) -0.083815
COMMENT: PROPOSED_MF MS-FINDER 3.473; C15H32N4O5; [M+Na]+; delta(ppm) 24811.554507
COMMENT: PROPOSED_MF MS-FINDER 3.050; C17H30N4O5; [M+H]+; delta(ppm) -3.686482
COMMENT: PROPOSED_MF MS-FINDER 2.727; C11H31N8O4P; [M+H]+; delta(ppm) -0.902325
COMMENT: PROPOSED_MF MS-FINDER 2.555; C17H38O4S2; [M+H]+; delta(ppm) -2.424739
COMMENT: PROPOSED_MF MS-FINDER 2.446; C8H32N10O3S; [M+Na]+; delta(ppm) 24809.614314
COMMENT: PROPOSED_MF MS-FINDER 2.427; C11H39N4O3PS2; [M+H]+; delta(ppm) 0.359425
COMMENT: PROPOSED_MF MS-FINDER 2.363; C15H40O4S2; [M+Na]+; delta(ppm) 24812.879647
COMMENT: PROPOSED_MF MS-FINDER 2.286; C21H30N4S; [M+H]+; delta(ppm) 3.053612
COMMENT: PROPOSED_MF MS-FINDER 2.273; C13H26N10O3; [M+H]+; delta(ppm) 3.547160
COMMENT: PROPOSED_MF MS-FINDER 2.212; C13H32N8O2; [M+K]+; delta(ppm) 117265.855397
COMMENT: PROPOSED_MF MS-FINDER 2.103; C16H28N8O; [M+Na]+; delta(ppm) 24807.770847
COMMENT: PROPOSED_MF MS-FINDER 2.059; C13H40N4OS2; [M+K]+; delta(ppm) 117267.430420
COMMENT: PROPOSED_MF MS-FINDER 1.920; C16H36N4S2; [M+Na]+; delta(ppm) 24809.095977
COMMENT: PROPOSED_MF MS-FINDER 1.817; C10H38N6O2S3; [M+H]+; delta(ppm) -4.272112
COMMENT: PROPOSED_MF MS-FINDER 1.808; C13H34N6O2S2; [M+H]+; delta(ppm) 4.808921
COMMENT: PROPOSED_MF SIRIUS5_Sirius 20.798; C16H34O9; [M+H]+; delta(ppm) -0.083815
COMMENT: PROPOSED_MF SIRIUS5_Sirius 16.802; C17H30N4O5; [M+H]+; delta(ppm) -3.686482
COMMENT: PROPOSED_MF SIRIUS5_Sirius 16.456; C15H32N4O5; [M+Na]+; delta(ppm) 24811.554507
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.162; C20H34O4S; [M+H]+; delta(ppm) 6.656327
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.397; C20H32N2O3; [M+Na]+; delta(ppm) 24800.173908
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C19H32N4S; [M+Na]+; delta(ppm) 24818.633268
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C21H30N4S; [M+H]+; delta(ppm) 3.053612
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.729; C18H34N4S2; [M+H]+; delta(ppm) -6.027389
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C15H32N4O5; [M+Na]+; delta(ppm) 24811.554507
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.994; C16H34O9; [M+H]+; delta(ppm) -0.083815
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.006; C17H30N4O5; [M+H]+; delta(ppm) -3.686482
COMMENT: PROPOSED_MF SIRIUS6_Sirius 30.577; C16H34O9; [M+H]+; delta(ppm) -0.083815
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.581; C17H30N4O5; [M+H]+; delta(ppm) -3.686482
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.235; C15H32N4O5; [M+Na]+; delta(ppm) 24811.554507
COMMENT: PROPOSED_MF SIRIUS6_Sirius 23.855; C15H35N2O6P; [M+H]+; delta(ppm) -8.135902
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.941; C20H34O4S; [M+H]+; delta(ppm) 6.656327
COMMENT: PROPOSED_MF SIRIUS6_Sirius 20.555; C17H36N2O4; [M+K]+; delta(ppm) 117256.825837
COMMENT: PROPOSED_MF SIRIUS6_Sirius 20.471; C15H28N7O4; [M+H]+; delta(ppm) -0.069674
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.078; C12H30N6O7; [M+H]+; delta(ppm) 7.149878
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.066; C17H34NO6; [M+Na]+; delta(ppm) 24807.755995
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.891; C14H31FN4O6; [M+H]+; delta(ppm) -6.764491
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.901; C19H32NO6; [M+H]+; delta(ppm) -7.303263
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.655; C16H30B2O8; [M+H]+; delta(ppm) 57021.944695
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.551; C11H31N8O4P; [M+H]+; delta(ppm) -0.902325
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.982; C20H32N2O3; [M+Na]+; delta(ppm) 24800.173908
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.288; C13H30N7O4; [M+Na]+; delta(ppm) 24815.353046
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.573; C18H30N5O2; [M+Na]+; delta(ppm) 24803.972363
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.528; C11H28N10O3; [M+Na]+; delta(ppm) 24819.151614
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.496; C16H28N8O; [M+Na]+; delta(ppm) 24807.770847
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.838; C13H29FN8O2; [M+Na]+; delta(ppm) 24804.538202
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.803; C15H34N5O3; [M+K]+; delta(ppm) 117261.340599
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.431; C13H32N8O2; [M+K]+; delta(ppm) 117265.855397
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.701; C14H33N6O2P; [M+Na]+; delta(ppm) 24803.097894
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.429; C16H35N3O3P; [M+Na]+; delta(ppm) 24799.299445
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.473; C16H36N4OS; [M+K]+; delta(ppm) 117278.766260
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.455; C11H30N11O; [M+K]+; delta(ppm) 117270.370231
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.618; C18H38NO2S; [M+K]+; delta(ppm) 117274.251358
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.525; C9H28N14; [M+K]+; delta(ppm) 117274.885102
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.605; C22H37P; [M+K]+; delta(ppm) 117271.020830
COMMENT: PROPOSED_MF SIRIUS6_Sirius -5.215; C19H41PS; [M+K]+; delta(ppm) 117259.685147
COMMENT: PROPOSED_MF SIRIUS6_Sirius -9.157; C18H40NP2; [M+K]+; delta(ppm) 117269.981437
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C16H34O9; [M+H]+; delta(ppm) -0.083815
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C17H36N2O4; [M+K]+; delta(ppm) 117256.825837
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C15H32N4O5; [M+Na]+; delta(ppm) 24811.554507
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.581; GLZWNFNQMJAZGY-UHFFFAOYSA-N; [M+H]+; OCCOCCOCCOCCOCCOCCOCCOCCO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; AMJDVGHRJYTJTI-UHFFFAOYSA-N; [M+H]+; O=C(NCC1CCCN2CCCCC21)C=3C=NN(C=4C=CC=C(F)C4)C3C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; PJAZASHQRNORRS-UHFFFAOYSA-N; [M+H]+; O=C(NCC1CCCN2CCCCC21)C=3C=NN(C=4C=CC=CC4F)C3C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; QNKFHWXFAYFMNS-UHFFFAOYSA-N; [M+H]+; O=C(NCC1CCCN2CCCCC21)C=3C=NN(C4=CC=C(F)C=C4)C3C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; RKEGIDYWABTJLP-UHFFFAOYSA-N; [M+H]+; O=C(NCC1CCCN2CCCCC21)C3=CC(=NN3C)C=4C=CC(F)=CC4
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.065; GLZWNFNQMJAZGY-UHFFFAOYSA-N; [M+H]+; Octaethylene glycol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.799; WFMQYKIRAVMXSU-UHFFFAOYNA-N; [M+Na]+; Fortimicin B
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.527; AZDJKZUXCACOJN-UHFFFAOYSA-N; [M+H]+; N-{5-[(4-acetyl-1,4-diazepan-1-yl)methyl]-4-hydroxyoxolan-3-yl}morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.471; KOUKBYBJIRNVCS-UHFFFAOYSA-N; [M+H]+; N-({4-[(1-acetylpiperidin-4-yl)amino]-3-hydroxyoxolan-2-yl}methyl)morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.466; VCXFLVXPVZGLAW-UHFFFAOYSA-N; [M+H]+; 6-amino-2-{4-methyl-2-[(5-oxopyrrolidin-2-yl)formamido]pentanamido}hexanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.461; RUQBGIMJQUWXPP-CYDGBPFRSA-N; [M+H]+; Ala-Leu-Ala-Pro
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.461; NVAVYRWRQSKURM-UHFFFAOYSA-N; [M+H]+; 6-amino-2-{3-methyl-2-[(5-oxopyrrolidin-2-yl)formamido]pentanamido}hexanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.421; ASHBUDSYSKWCHM-UHFFFAOYSA-N; [M+H]+; N-{3-[(1-carbamoylethyl)carbamoyl]-5,6-dihydroxycyclohex-2-en-1-yl}-4-methyl-2-(methylamino)pentanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.421; CNBPPNBRAKXRHC-UHFFFAOYSA-N; [M+H]+; CNP0429512
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.421; YNLKVAXSLPWACK-UHFFFAOYSA-N; [M+H]+; 2-({4,5-dihydroxy-3-[(propylcarbamoyl)amino]cyclohex-1-en-1-yl}formamido)-4-methylpentanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.421; ZEOOSLNEPOLNNT-UHFFFAOYSA-N; [M+H]+; CNP0450469
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; YNLKVAXSLPWACK-UHFFFAOYSA-N; [M+H]+; 2-({4,5-dihydroxy-3-[(propylcarbamoyl)amino]cyclohex-1-en-1-yl}formamido)-4-methylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GLZWNFNQMJAZGY-UHFFFAOYSA-N; [M+H]+; Octaethylene glycol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WFMQYKIRAVMXSU-UHFFFAOYNA-N; [M+Na]+; Fortimicin B
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.997; ZEOOSLNEPOLNNT-UHFFFAOYSA-N; [M+H]+; CNP0450469
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.647; KOUKBYBJIRNVCS-UHFFFAOYSA-N; [M+H]+; N-({4-[(1-acetylpiperidin-4-yl)amino]-3-hydroxyoxolan-2-yl}methyl)morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.645; AZDJKZUXCACOJN-UHFFFAOYSA-N; [M+H]+; N-{5-[(4-acetyl-1,4-diazepan-1-yl)methyl]-4-hydroxyoxolan-3-yl}morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.581; NVAVYRWRQSKURM-UHFFFAOYSA-N; [M+H]+; 6-amino-2-{3-methyl-2-[(5-oxopyrrolidin-2-yl)formamido]pentanamido}hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.581; VCXFLVXPVZGLAW-UHFFFAOYSA-N; [M+H]+; 6-amino-2-{4-methyl-2-[(5-oxopyrrolidin-2-yl)formamido]pentanamido}hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.573; ASHBUDSYSKWCHM-UHFFFAOYSA-N; [M+H]+; N-{3-[(1-carbamoylethyl)carbamoyl]-5,6-dihydroxycyclohex-2-en-1-yl}-4-methyl-2-(methylamino)pentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.573; CNBPPNBRAKXRHC-UHFFFAOYSA-N; [M+H]+; CNP0429512
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.090; RUQBGIMJQUWXPP-CYDGBPFRSA-N; [M+H]+; Ala-Leu-Ala-Pro
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; GLZWNFNQMJAZGY-UHFFFAOYSA-N; [M+H]+; 2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -51.638; GLZWNFNQMJAZGY; [M+H]+; PED-diol (n=8)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -254.772; WFMQYKIRAVMXSU; [M+Na]+; Fortimicin B
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.572; GLZWNFNQMJAZGY; [M+H]+; PED-diol (n=8)
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.282; WFMQYKIRAVMXSU; [M+Na]+; Fortimicin B
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -11.291; GLZWNFNQMJAZGY; [M+H]+; 3,6,9,12,15,18,21-heptaoxatricosane-1,23-diol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -234.089; QMXUUWRYSDULNM; [M+K]+; 1-[2-[2-(2-Methoxyethoxy)ethoxy]ethyl]-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -237.205; FMPKKSLBKSXZHF; [M+K]+; 1-[2-[2-[2-(2-Butoxyethoxy)ethoxy]ethoxy]ethyl]piperidin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -238.584; WGRQPKMJCLQTFO; [M+K]+; 2-[2-[2-[2-[(1-Tert-butylpiperidin-4-yl)amino]ethoxy]ethoxy]ethoxy]ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -243.325; MZMKIJZSXDFESA; [M+K]+; 2-[2-[2-[2-[4-(2-Methylbutan-2-yl)piperazin-1-yl]ethoxy]ethoxy]ethoxy]ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -258.954; BPBLOELQMHULDC; [M+K]+; 2-[Bis(2-hydroxypropyl)amino]ethyl-bis(2-hydroxypropyl)-prop-2-enylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -268.040; LUQPILAMIXOCCR; [M+K]+; N-heptyl-3-[2-[2-[2-(methylamino)ethoxy]ethoxy]ethoxy]propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -273.074; ZMJQPQYKJJYKJD; [M+K]+; N-pentyl-3-[2-[2-[2-(propan-2-ylamino)ethoxy]ethoxy]ethoxy]propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -280.176; QLPLTAJCUBVIHN; [M+K]+; N-[6-[2-[2-[2-(propan-2-ylamino)ethoxy]ethoxy]ethoxy]hexyl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -290.990; HIAFSDAHSRXJEZ; [M+K]+; tert-butyl N-[4-(2-butoxyethylamino)-5-methoxypentyl]carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -296.951; OIKDBDZGPRKZHM; [M+K]+; tert-butyl N-ethyl-N-[2-[[hydroxy-[(2-methylpropan-2-yl)oxy]methyl]-propylamino]ethyl]carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -392.912; WFMQYKIRAVMXSU; [M+Na]+; 1-Epi-Ft-B
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.658; GLZWNFNQMJAZGY; [M+H]+; 3,6,9,12,15,18,21-heptaoxatricosane-1,23-diol
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.058; QMXUUWRYSDULNM; [M+K]+; 1-[2-[2-(2-Methoxyethoxy)ethoxy]ethyl]-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.037; WFMQYKIRAVMXSU; [M+Na]+; 1-Epi-Ft-B
COMMENT: CONFIDENCE Level 3: Tentative candidate, Octaethylene glycol, GLZWNFNQMJAZGY-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0094680;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C16H34O9
CH$EXACT_MASS: 370.220283
CH$SMILES: C(COCCOCCOCCOCCOCCOCCOCCO)O
CH$IUPAC: InChI=1S/C16H34O9/c17-1-3-19-5-7-21-9-11-23-13-15-25-16-14-24-12-10-22-8-6-20-4-2-18/h17-18H,1-16H2
CH$LINK: CHEBI CHEBI:44794
CH$LINK: HMDB HMDB0094680
CH$NAME: Octaethylene glycol
CH$NAME: Octaethylene glycol
CH$NAME: 2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
CH$LINK: INCHIKEY GLZWNFNQMJAZGY-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:78798
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 4.883
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 371.227528
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0019-9500000000-ec6de569037dca9a45f0
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  73.0468921 17.6035 73.047634 0.9309 4.94 0.1620 18 ?
  87.0440783 49.2875 87.044780 1.1029 9.08 0.7470 24 f{C4H7O2}/0.26ppm,p-C12H28O7
  89.0597453 999.0000 89.060437 0.2695 0.00 1.0000 24 f{C4H9O2}/0.44ppm,p-C12H26O7
  90.0630743 39.6397 90.063760 1.3324 9.05 0.7324 22 ?
  91.0573797 22.9100 91.058059 1.4277 10.98 -0.4035 18 ?
  133.0859782 512.8863 133.086276 0.3006 27.20 0.9739 24 f{C6H13O3}/0.43ppm,p-C10H22O6
  177.1121847 124.7444 177.112563 0.9260 13.52 0.9678 24 f{C8H17O4}/0.28ppm,p-C8H18O5
PK$NUM_PEAK: 7
PK$PEAK: m/z int. rel.int.
  73.046892 17.60 17
  87.044078 49.29 49
  89.059745 999.00 999
  90.063074 39.64 39
  91.057380 22.91 22
  133.085978 512.89 512
  177.112185 124.74 124
//
